Pulmonary alveolar microlithiasis (PAM) is a rare lung disease that has only been recorded about 700 times in medical literature. In order for someone to get PAM, both parents must have the genetic mutation that causes it. Although rare, this disease can result in a much shorter life expectancy or death. With the help of a new grant worth $1.6 million over the next four years from the National Heart, Lung, and Blood Institute of the NIH, researchers at the University of Cincinnati will further study this rare disease. (Image courtesy of Wikimedia Commons)
Read More
